Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial

Adel Ganaw, Kayleigh Griffiths, Moad Ehfeda, Ashraf Elmalik, Manoj Varghese, Muna Al Maslamani, Prem Chandra, Hugh Montgomery, Melanie Madhani

Open source

DOI
10.2196/81541
Published
2026-09-11
Container
JMIR Research Protocols
Publisher
JMIR Publications Inc.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2196/81541,
  title = {Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial},
  author = {Adel Ganaw and Kayleigh Griffiths and Moad Ehfeda and Ashraf Elmalik and Manoj Varghese and Muna Al Maslamani and Prem Chandra and Hugh Montgomery and Melanie Madhani},
  year = {2026},
  journal = {JMIR Research Protocols},
  doi = {10.2196/81541},
  url = {https://doi.org/10.2196/81541}
}

RIS

TY  - JOUR
TI  - Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial
AU  - Adel Ganaw
AU  - Kayleigh Griffiths
AU  - Moad Ehfeda
AU  - Ashraf Elmalik
AU  - Manoj Varghese
AU  - Muna Al Maslamani
AU  - Prem Chandra
AU  - Hugh Montgomery
AU  - Melanie Madhani
PY  - 2026
JO  - JMIR Research Protocols
DO  - 10.2196/81541
UR  - https://doi.org/10.2196/81541
ER  - 

APA

Ganaw, A., Griffiths, K., Ehfeda, M., Elmalik, A., Varghese, M., Maslamani, M. A., Chandra, P., Montgomery, H., & Madhani, M. (2026). Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/81541

Source records